Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 785 across all filing types
Latest filing 2018-01-03 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
CLOSING UNDER THE SHARE EXCHANGE AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding the completion of a share exchange agreement, specifically the closing of a transaction where the company became the largest shareholder of another entity. It references prior circulars and announcements related to the transaction but does not contain financial statements or detailed financial data. The content focuses on a corporate transaction update rather than a full report or financial disclosure. The document length is short (1865 characters), and it is an announcement of a transaction closing rather than a detailed report or presentation. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2018-01-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content is focused on share capital changes and movements during a specific month, which is typical of a regulatory filing related to share capital disclosures. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory report on share capital movements rather than a financial report or announcement of a report. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2018-01-02 English
DELAY IN THE CLOSING UNDER THE SHARE EXCHANGE AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding a delay in the closing under a Share Exchange Agreement. It references previous circulars and poll results announcements but does not contain financial statements or detailed financial data. The content focuses on an update about the timing of a transaction closing, which is a capital or financing activity. The document length is short (2150 characters), and it is an announcement rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP).
2017-12-29 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content focuses exclusively on share capital changes and movements in securities, with no financial performance data, management discussion, or earnings information. It is a regulatory filing reporting share capital movements for a specific month, not a full financial report or earnings release. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a compliance document reporting share capital movements to the exchange.
2017-12-04 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 1 DECEMBER 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on 1 December 2017. It details the voting outcomes on resolutions related to a share exchange agreement and investor rights agreement. The text includes specific vote counts and percentages, confirms the passing of the resolution, and provides procedural notes about the meeting and voting process. There is no financial data, no detailed report content, and no indication that this is a full report or presentation. The document is clearly a declaration of voting results from a shareholder meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is moderate and contains detailed voting results, not just a brief notice or a link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is DVA with high confidence.
2017-12-01 English
Form of Proxy for use at the Extraordinary General Meeting to be held on Friday, December 1, 2017
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for use at an Extraordinary General Meeting (EGM) of PW Medtech Group Limited. It includes instructions for shareholders to appoint proxies to vote on resolutions related to a share exchange agreement and investor rights agreement. The content is procedural and related to voting at a shareholder meeting, not a report or announcement of financial results or management changes. It is not a report itself but a proxy solicitation document for voting purposes at a meeting. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (6809 characters) supports it being a full proxy form rather than a brief announcement.
2017-11-13 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.